WO2012008810A2 - Microorganism with enhanced l-lysine productivity and method for producing l-lysine using the same - Google Patents
Microorganism with enhanced l-lysine productivity and method for producing l-lysine using the same Download PDFInfo
- Publication number
- WO2012008810A2 WO2012008810A2 PCT/KR2011/005252 KR2011005252W WO2012008810A2 WO 2012008810 A2 WO2012008810 A2 WO 2012008810A2 KR 2011005252 W KR2011005252 W KR 2011005252W WO 2012008810 A2 WO2012008810 A2 WO 2012008810A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lysine
- activity
- microorganism
- producing
- gluconate kinase
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Definitions
- the present invention relates to a microorganism with high L-lysine productivity and a method for producing L-lysine using the same.
- L-Lysine is synthesized from oxaloacetic acid via the lysine biosynthetic pathway.
- the enzymes important to the biosynthesis of L-lysine are aspartate semialdehyde dehydrogenase, dihydrodipicolinate reductase and diaminopimelate dehydrogenase, which are respectively encoded by the genes asd, dapB and ddh, and which are NADPH-dependent reductases that mediate parts of the lysine biosynthetic pathway.
- the production of one molecule of L-lysine directly requires the consumption of three molecules of NADPH by the enzymes and one molecule of NADPH indirectly.
- the main supply routes of NADPH are the TCA cycle and the pentose phosphate pathway. It is preferred that the reducing power necessary for the production of L-lysine be supplied via oxidation pathway of the pentose phosphate pathway.
- the pentose phosphate pathway is economically more beneficial in terms of carbon metabolism yield because the operation of two cycles of the pentose phosphate pathway releases one CO 2 molecule with the concomitant production of two NADPH molecules whereas two CO 2 molecules are released per one TCA cycle, with the concomitant production of one NADPH molecule.
- a higher yield of L-lysine requires a greater supply of NADPH, resulting in a higher dependence on the pentose phosphate pathway.
- G6PDH Glucose-6-phosphate dehydrogenase
- 6PGD 6-phosphogluconate dehydrogenase
- L-amino acid-producing Corynebacterium strains when genes encoding enzymes responsible for the production of NADPH in the pentose phosphate pathway are enhanced or when the enzymes are mutated, L-amino acid productivity is reported to be increased.
- J. Becker et al. reported that the provision of a stronger promoter for the zwf gene encoding G6PDH in L-lysine-producing C. glutamicum brought about a significant increase in lysine production (J. Becker et al., J Biotechnol 132: 99-109, 2007).
- European Patent No. 1302537 discloses a method for producing L-amino acids by culturing L-amino acid-producing corynebacteria into a gene encoding a mutant of 6PGD which has been introduced.
- the present invention can produce L-amino acids in need of NADPH for their biosynthesis at high efficiency and yield, especially L-lysine, via increasing the intracellular level of NADPH in Corynebacterium strains.
- FIG. 1 is a schematic diagram illustrating the pentose phosphate pathway in Corynebacterium glutamicum ;
- FIG. 3 is a schematic diagram illustrating the pDZ- ⁇ NCgl2905 vector for marker-free deletion of the chromosomal NCgl2905 gene of Corynebacterium.
- the present invention provides an L-lysine-producing microorganism that has a gluconate kinase (GntK) activity weakened in comparison with the endogenous activity.
- GntK gluconate kinase
- L-lysine is a basic ⁇ -amino acid with the chemical formula of NH 2 (CH 2 ) 4 CH(NH 2 )COOH. It is an essential amino acid, which means that the human body cannot synthesize it.
- L-lysine is synthesized from oxaloacetic acid via the lysine biosynthesis pathway a part of which is catalyzed by NADPH-dependent reductases. The biosynthesis of one L-lysine molecule via this pathway requires the direct consumption of three NADPH molecules by enzymes, with the indirect use of one NADPH molecule.
- GntK glucose kinase
- GntK glycose phosphate pathway
- Microorganisms of Corynebacterium spp. operate both pathways, that is, the G6PDH and GntK pathways, to synthesize 6-phosphogluconic acid, an intermediate of the pentose phosphate pathway (FIG. 1), which means that microorganisms of Corynebacterium spp. may partially degrade glucose via the GntK pathway.
- the present inventors suggest that the blockage of the GntK pathway gives rise to a specific increase in the activity of 6-phosphogluconate dehydrogenase (6PGD), thus increasing the regeneration of NADPH.
- 6-phosphogluconate dehydrogenase (6PGD)
- the activity of the enzyme which is presumed to act as gluconate kinase (GntK) in microorganisms is weakened.
- the enzyme having gluconate kinase (GntK) activity may be NCgl2399 represented by the amino acid sequence of SEQ ID NO: 1 or NCgl2905 represented by the amino acid sequence of SEQ ID NO: 2.
- endogenous activity is intended to mean the activity of an enzyme in a native microorganism, and particularly when used in combination with GntK, refers to the activity of GntK that a native microorganism exhibits.
- the term “weakness of endogenous activity” is achieved on a chromosome containing a polynucleotide encoding an endogenous protein in a microorganism, by a method selected from the group consisting of a whole or partial deletion of the polynucleotide sequence, partial substitution of the polynucleotide sequence, or at least one base pair insertion into the polynucleotide sequence.
- endogenous activity can be weakened by mutating a regulatory element for the polynucleotide sequence, where the mutation is achieved by whole or partial deletion, substitution, or insertion of the regulatory element.
- the regulatory element may be on the upstream or downstream of the polynucleotide sequence in a chromosome, preferably, the regulatory element may be a promoter, enhancer et, al , but the present invention is not limited thereto.
- the mutation of the polynucleotide may be achieved using a well-known method, such as a homologous recombination.
- GntK activity weakened in comparison to the endogenous activity is intended to mean that GntK activity is down-regulated by genetic mutation such as disruption and thus becomes lower than the endogenous activity of the enzyme in a native microorganism.
- the present invention provides microorganisms of Corynebacterium spp. with enhanced L-lysine productivity by disrupting GntK activity via introducing a recombinant vector represented by the cleavage map in Fig 2 or 3.
- the endogenous GntK activity can be weakened by whole or partial deletion, substitution or insertion on at least one of the chromosomal genes.
- endogenous GntK activity can be weakened by whole or partial deletion, partial substitution or insertion on a regulatory element for at least one of the chromosomal genes.
- a mutation by deletion, substitution or insertion of nucleotides may be allowed to occur on a gene encoding NCgl2399 or NCgl2905, or either one or both of the genes having nucleotide sequences of SEQ ID NOS: 3 and 4 which code respectively for NCgl2399 and NCgl2905, or on regulatory elements thereof, so that GntK does not function normally.
- a microorganism with gluconate kinase activity weakened in comparison with the endogenous activity thereof can be prepared by introducing a recombinant vector carrying a part of the gene encoding gluconate kinase thereinto to delete or mutate the endogenous gluconate kinase gene thereof.
- the insertion of the partial gene into the chromosome may be achieved using a well-known method, such as a homologous recombination.
- any strain may be used without limitation as a host cell into which the recombinant vector is introduced.
- Preferred are the microorganisms of Corynebacterium spp. or Brevibacterium spp.
- host cells useful in the present invention include C. glutamicum ATCC13032, C. thermoaminogenes FERM BP-1539, Brevibacterium flavum ATCC 14067, and Brevibacterium lactofermentum ATCC 13869, and L-amino acid-producing mutants or stains derived therefrom, such as C. glutamicum KFCC10881, C. glutamicum KFCC11001 and C. glutamicum KCCM10770P.
- C. glutamicum KFCC10881 In an embodiment of the present invention, C. glutamicum KFCC10881 was employed, but the present invention is not limited thereto.
- a part of a gene encoding NCgl2399 was inserted into a pDZ vector to construct a recombinant vector, called pDZ- ⁇ NCgl2399, which was then transformed into a Corynebacterium strain.
- the resulting recombinant Corynebacterium strain in which the chromosomal gene encoding NCg12399 was disrupted was named KFCC10881- ⁇ NCgl2399.
- a recombinant pDZ vector carrying a part of a gene encoding NCgl2905, named pDZ- ⁇ NCgl2905 was transformed into a Corynebacterium strain.
- the resulting recombinant strain in which the chromosomal gene encoding NCg12905 was disrupted was named KFCC10881- ⁇ NCgl2905. Further, KFCC10881- ⁇ NCgl2399 was transformed with the recombinant plasmid pDZ- ⁇ NCgl2905 to provide a mutant strain which was defective in both NCgl2399 and NCgl2905 genes.
- the strain was named C. glutamicum CA01-0892 and deposited with the Korean Culture Center of Microorganisms on June 24, 2010, under accession No. KCCM 11085P.
- the recombinant C. glutamicum strains were evaluated for intracellular gluconate kinase activity and NADPH level.
- the intracellular GntK activity of the strain which is defective in the NCgl2399 gene and the strain which is defective in both the NCgl2399 and NCg12905 gene were observed to have been decreased compared to the parent strain.
- intracellular NADPH level and 6PGD activity were observed to have been increased compared to the parent strain(Table 2).
- L-lysine production yield of the prepared strains were observed to have been increased compared to the parent strain(Table 3).
- the present invention provides a method for producing L-lysine, comprising the steps of: 1) culturing the microorganism of the present invention to obtain a cell culture; and 2)havesting L-lysine from the cell culture or the microorganism.
- the term “culturing” means allowing microorganisms to grow under artificially controlled conditions.
- Various methods well known in the art may be employed to culture the recombinants of the present invention.
- the cells may be cultured in a batch process or in a continuous process such as a fed-batch process or a repeated fed batch process, but the present invention is not limited thereto.
- Culture media suitable for use in culturing Corynebacteria strains are well known in the art (e.g., Manual of Methods for General Bacteriology, American Society for Bacteriology, Washington D.C., USA, 1981).
- Carbon sources of the culture media may be saccharides and carbohydrates such as glucose, sucrose, lactose, fructose, maltose, starch and cellulose; oils and lipids such as soybean oil, sunflower seed oil, peanut oil and coconut oil; fatty acids such as palmeatic acid, stearic acid, rinoleic acid;, alcohols such as glycerol and ethanol; and organic acids such as acetic acid.
- Examples of a nitrogen source useful for culturing the recombonants include peptone, yeast extract, broth, malt extract, corn steep liquor, soybean meal and urea, or inorganic compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate. These nitrogen sources may be used separately or in combination.
- phosphorus sources useful in the culture media are dipotassium hydrogen phosphate, potassium dihydrogen phosphate and corresponding sodium salts.
- culture media may contain metal salts essential to the growth of cells and may be supplemented with essential nutrients such as amino acids and vitamins.
- proper precursors may be added to the culture media. The nutrients or supplements may be added altogether once or in separation during cultivation.
- the pH of the culture media may be adjusted with a basic compound such as sodium hydroxide, potassium hydroxide or ammonia or an acidic compound such as phosphoric acid or sulfuric acid.
- the generation of foam in the culture media may be restrained using an anti-foaming agent such as fatty acid polyglycol ester.
- the culture media may be kept under aerobic conditions by introducing oxygen or an oxygen-containing gas (e.g., air) thereinto.
- the culture temperature is typically between 20 and 45°C and preferably between 25 and 40°C.
- the culturing is continued until a maximal amount of L-amino acid is produced. In this regard, it may be accomplished within 10 to 160 hrs.
- the L-lysine may be exported into the culture media or may remain within the cells.
- the method for the production of L-lysine in accordance with the present invention comprises harvesting lysine from the cells or the cell culture.
- L-lysine can be isolated from culture media or cells using a well-known method. Examples of the isolation method useful in the present invention include centrifugation, filtration, anionic exchange chromatography, crystallization and HPLC, but are not limited thereto.
- primers were designed.
- sequences of NCgl2399(SEQ ID NO: 1) and NCgl2905(SEQ ID NO: 2) were obtained from the NIH GenBank.
- the primers 2399F1, 2399F2, 2399R1, 2399R2, 2905F1, 2905F2, 2905R1, and 2905R2 were synthesized which would be used in constructing inactivation fragments of NCgl2399 or NCgl2905.
- Nucleotide sequences of the primers used in the present invention, along with their SEQ ID NOs., are summarized in Table 1 wherein restriction sites are underlined.
- pDZ Site-specific gene disruption was conducted with pDZ, which is incapable of replication in C. glutamicum .
- pDZ derivatives carrying respective internally defective open reading frames of NCgl2399 and NCgl2905 were constructed.
- the pDZ derivatives are pDZ- ⁇ NCgl2399 (FIG. 2) and pDZ- ⁇ NCgl2905 (FIG. 3).
- pDZ- ⁇ NCgl2399 carries an XbaI end and an internal gene defective at a KpnI site of a 2,267 bp-long NCgl2399.
- NCgl2399 The internal gene defective of NCgl2399 was generated using overlap extension PCR in the presence of 2399F1-2399R1 primers (SEQ ID NOS: 5 and 6) and 2399F2-2399R2 primers (SEQ ID NOS: 7 and 8), with the genomic DNA of C. glutamicum ATCC13032 serving as a template.
- pDZ- ⁇ NCgl2905 carries a XbaI end and an internal gene defective at a SmaI site of a 2,819 bp-long NCgl2905.
- the internal gene defective of NCgl2905 was generated using overlap extension PCR in the presence of 2905F1-2905R1 primers (SEQ ID NOS: 9 and 10) and 2905F2-2905R2 primers (SEQ ID NOS: 11 and 12), with the genomic DNA of C. glutamicum ATCC13032 serving as a template.
- the recombinant plasmids were transformed into wild-type Corynebacterium glutamicum using electroporation (van der Rest et al., Appl Microbiol Biotechnol 52:541-545, 1999) and incorporated into the chromosome by primary recombination (crossover). Then, the plasmids were excised from the chromosomes by secondary recombination (crossover) on an agar plate containing 10% sucrose.
- NCgl2399 and NCgl2905 were named KFCC10881- ⁇ NCgl2399 and KFCC10881- ⁇ NCgl2905, respectively.
- the open reading frame DNA sequences of NCgl2399 and NCgl2905 are referred to GenBank Accession No. NC_003450.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
- An L-lysine-producing microorganism, having gluconate kinase (GntK) activity weakened in comparison with the endogenous activity thereof.
- The L-lysine-producing microorganism of claim 1, wherein the gluconate kinase has an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2.
- The L-lysine-producing microorganism of claim 1, wherein the microorganism belongs to a Corynebacterium sp.
- The L-lysine-producing microorganism of claim 1, wherein the endogenous gluconate kinase activity is weakened by whole or partial deletion, partial substitution or insertion on a chromosomal gene encoding gluconate kinase.
- The L-lysine-producing microorganism of claim 1, wherein the endogenous gluconate kinase activity is weakened by whole or partial deletion, partial substitution or insertion on a regulatory element for a chromosomal gene encoding gluconate kinase.
- The L-lysine-producing microorganism of claim 1, wherein when there are two or more chromosomal genes coding proteins having gluconate kinase activity and having different amino acid sequences to each other, the endogenous gluconate kinase activity is weakened by whole or partial deletion, substitution or insertion on at least one of the chromosomal genes; or whole or partial deletion, partial substitution or insertion on a regulatory element for at least one of the chromosomal genes.
- The L-lysine-producing microorganism of claim 1, which is derived from Corynebacterium glutamicum KFCC10881.
- The L-lysine-producing microorganism of claim 1, identified as Corynebacterium glutamicum CA01-0892 deposited under accession No. KCCM 11085P.
- A method for preparing the L-lysine-producing microorganism as in one of claims 1-8, comprising the steps of:1) constructing a polynucleotide fragment encoding gluconate kinase (GntK) having a weakened activity by wholly or partially mutating said polynucleotide;2) inserting the polynucleotide fragment into a vector to afford a recombinant vector, said vector being capable of homologous recombination with a chromosome in a host cell;3) introducing the recombinant vector into a host cell capable of producing L-lysine to form homologous recombinants; and4) selecting a strain having a GntK activity weakened in comparison to the endogenous activity thereof, from the homologous recombinants.
- A method for producing L-lysine, comprising the steps of:1) culturing the microorganism as in one of claims 1-8 to obtain a cell culture; and2) harvesting L-lysine from the cell culture or the microorganism.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012524667A JP5682072B2 (en) | 2010-07-15 | 2011-07-15 | Production method of L-lysine |
ES11791415.0T ES2603128T3 (en) | 2010-07-15 | 2011-07-15 | Microorganism with enhanced L-lysine productivity and L-lysine production process using the same |
CN201180002405.3A CN102741393B (en) | 2010-07-15 | 2011-07-15 | The microorganism that 1B productivity improves and the method with its production 1B |
EP11791415.0A EP2430152B1 (en) | 2010-07-15 | 2011-07-15 | Microorganism with enhanced l-lysine productivity and method for producing l-lysine using the same |
BRPI1106092A BRPI1106092A2 (en) | 2010-07-15 | 2011-07-15 | microorganism with increased l-lysine productivity and method for producing l-lysine with it |
US13/378,145 US20130102037A1 (en) | 2010-07-15 | 2011-07-15 | Microorganism with Enhanced L-Lysine Productivity and Method for Producing L-Lysine Using the Same |
DK11791415.0T DK2430152T3 (en) | 2010-07-15 | 2011-07-15 | A microorganism with increased L-lysine productivity and method for producing L-lysine using the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20100068618 | 2010-07-15 | ||
KR10-2010-0068618 | 2010-07-15 | ||
KR10-2011-0065694 | 2011-07-01 | ||
KR1020110065694A KR101269810B1 (en) | 2010-07-15 | 2011-07-01 | A microorganism having enhanced L-lysine productivity and a method of producing L-lysine using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012008810A2 true WO2012008810A2 (en) | 2012-01-19 |
WO2012008810A3 WO2012008810A3 (en) | 2012-05-24 |
Family
ID=45469967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/005252 WO2012008810A2 (en) | 2010-07-15 | 2011-07-15 | Microorganism with enhanced l-lysine productivity and method for producing l-lysine using the same |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2430152B1 (en) |
WO (1) | WO2012008810A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104561050A (en) * | 2013-10-15 | 2015-04-29 | Cj第一制糖株式会社 | Genes encoding biofilm formation inhibitory proteins and method for producing L-lysine using bacterial strain with the inactivated genes |
CN107488671A (en) * | 2017-10-19 | 2017-12-19 | 江苏大学 | A kind of optimization gene, expression vector and the application of 2 ketone group gluconokinase |
EP3318637A4 (en) * | 2015-07-03 | 2018-12-12 | CJ Cheiljedang Corporation | Microorganism having l-lysine productivity and method for producing l-lysine by using same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1302537A1 (en) | 2000-06-21 | 2003-04-16 | Kyowa Hakko Kogyo Co., Ltd. | Novel glucose-6-phosphate dehydrogenase |
KR100924065B1 (en) | 2006-09-15 | 2009-10-27 | 씨제이제일제당 (주) | A corynebacteria having enhanced L-lysine productivity and a method of producing L-lysine using the same |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4623825B2 (en) * | 1999-12-16 | 2011-02-02 | 協和発酵バイオ株式会社 | Novel polynucleotide |
AU2002314738A1 (en) * | 2001-04-04 | 2002-10-21 | Genencor International, Inc. | Methods for the production of products in host cells |
MXPA05012413A (en) * | 2003-05-22 | 2006-02-13 | Genencor Int | Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters. |
KR100789270B1 (en) * | 2005-11-30 | 2008-01-02 | 씨제이 주식회사 | - - A microorganism of corynebacterium genus having enhanced L-lysine productivity and a method of producing L-lysine using the same |
KR100789271B1 (en) * | 2005-11-30 | 2008-01-02 | 씨제이 주식회사 | - - A microorganism of corynebacterium genus having enhanced L-lysine productivity and a method of producing L-lysine using the same |
KR100838038B1 (en) * | 2006-12-29 | 2008-06-12 | 씨제이제일제당 (주) | - - a microorganism of corynebacterium genus having enhanced l-lysine productivity and a method of producing l-lysine using the same |
KR100838035B1 (en) * | 2006-12-29 | 2008-06-12 | 씨제이제일제당 (주) | - - a microorganism of corynebacterium genus having enhanced l-lysine productivity and a method of producing l-lysine using the same |
KR101300185B1 (en) * | 2010-07-15 | 2013-08-26 | (주)강원지역대학연합기술지주회사 | A microorganism having enhanced L-ornithine productivity and a method of producing L-ornithine using the same |
-
2011
- 2011-07-15 WO PCT/KR2011/005252 patent/WO2012008810A2/en active Application Filing
- 2011-07-15 EP EP11791415.0A patent/EP2430152B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1302537A1 (en) | 2000-06-21 | 2003-04-16 | Kyowa Hakko Kogyo Co., Ltd. | Novel glucose-6-phosphate dehydrogenase |
KR100924065B1 (en) | 2006-09-15 | 2009-10-27 | 씨제이제일제당 (주) | A corynebacteria having enhanced L-lysine productivity and a method of producing L-lysine using the same |
Non-Patent Citations (8)
Title |
---|
FRUNZKE ET AL., MOL MICROBIOL, vol. 67, 2008, pages 305 - 322 |
J. BECKER ET AL., J BIOTCCHNOL, vol. 132, 2007, pages 99 - 109 |
MARX ET AL., BIOTECHNOL BIOENG, vol. 56, 1997, pages 168 - 180 |
MARX ET AL., J BIOTECHNOL, vol. 104, 2003, pages 185 - 197 |
OHNISHI ET AL., MICROBIOL LETT, vol. 242, 2005, pages 265 - 274 |
See also references of EP2430152A4 |
VAN DER REST ET AL., APPI MICROBIOL BIOTECHNOL, vol. 52, 1999, pages 541 - 545 |
WITTMANN; HEINZLE, MICROBIOL, vol. 68, 2002, pages 5843 - 5849 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104561050A (en) * | 2013-10-15 | 2015-04-29 | Cj第一制糖株式会社 | Genes encoding biofilm formation inhibitory proteins and method for producing L-lysine using bacterial strain with the inactivated genes |
EP2862932A3 (en) * | 2013-10-15 | 2015-07-01 | CJ Cheiljedang Corporation | Genes encoding biofilm formation inhibitory proteins and a method for producing l-lysine using a bacterial strain with the inactivated genes |
EP2930242A1 (en) * | 2013-10-15 | 2015-10-14 | CJ Cheiljedang Corporation | Genes encoding biofilm formation inhibitory proteins and a method for producing l-lysine using a bacterial strain with the inactivated genes |
US9556463B2 (en) | 2013-10-15 | 2017-01-31 | Cj Cheiljedang Corporation | Genes encoding biofilm formation inhibitory proteins and a method for producing L-lysine using a bacterial strain with the inactivated genes |
CN107099469A (en) * | 2013-10-15 | 2017-08-29 | Cj第制糖株式会社 | The method that the formation of encoding human film is suppressed the gene of protein and L lysines are produced using the bacterium bacterial strain with inactivated gene |
CN104561050B (en) * | 2013-10-15 | 2019-08-02 | Cj第一制糖株式会社 | Encoding human film forms the gene for inhibiting protein and the method using the bacterium bacterial strain production L-lysine with inactivated gene |
CN107099469B (en) * | 2013-10-15 | 2020-08-28 | Cj第一制糖株式会社 | Gene encoding biofilm formation inhibitory protein and method for producing L-lysine using bacterial strain having inactivated gene |
EP3318637A4 (en) * | 2015-07-03 | 2018-12-12 | CJ Cheiljedang Corporation | Microorganism having l-lysine productivity and method for producing l-lysine by using same |
CN107488671A (en) * | 2017-10-19 | 2017-12-19 | 江苏大学 | A kind of optimization gene, expression vector and the application of 2 ketone group gluconokinase |
CN107488671B (en) * | 2017-10-19 | 2019-10-29 | 江苏大学 | A kind of optimization gene, expression vector and the application of 2- ketone group gluconokinase |
Also Published As
Publication number | Publication date |
---|---|
EP2430152A4 (en) | 2013-07-10 |
EP2430152A2 (en) | 2012-03-21 |
WO2012008810A3 (en) | 2012-05-24 |
EP2430152B1 (en) | 2016-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6695308B2 (en) | Corynebacterium genus having improved L-lysine production ability and L-lysine production method using the same | |
JP6219481B2 (en) | Method for producing L-lysine using a microorganism having L-lysine producing ability | |
WO2009125992A2 (en) | Vector for transformation using transposons, microorganisms transformed by the vector, and method for producing l-lysine using the same | |
US7794990B2 (en) | Microorganism of corynebacterium genus having enhanced L-lysine production ability and method of producing L-lysine using the same | |
WO2014208981A1 (en) | Microorganism with enhanced l-lysine productivity and method for producing l-lysine by using same | |
WO2009096690A2 (en) | Improved promoter, and a production method for l-lysine using the same | |
WO2021162189A1 (en) | Corynebacterium glutamicum mutant strain having improved l-glutamic acid production ability, and method for producing l-glutamic acid using same | |
WO2012008809A2 (en) | Microorganism having improved l-ornithine productivity, and method for producing l-ornithine using same | |
WO2016171392A1 (en) | Gluconate repressor variant, l-lysine producing microorganism comprising same, and method for producing l-lysine using same | |
WO2011115439A2 (en) | Microorganism with improved production of 5'-xanthosine monophosphate and 5'-guanine monophosphate, and production method of 5'-xanthosine monophosphate and 5'-guanine monophosphate using same | |
US20130102037A1 (en) | Microorganism with Enhanced L-Lysine Productivity and Method for Producing L-Lysine Using the Same | |
CA1306963C (en) | Process for producing l-threonine and l-isoleucine | |
WO2012008810A2 (en) | Microorganism with enhanced l-lysine productivity and method for producing l-lysine using the same | |
WO2010071367A2 (en) | A corynebacteria strain having enhanced 5'-xanthosine monophosphate productivity and a method of producing 5'-xanthosine monophosphate using the same | |
WO2022191357A1 (en) | Corynebacterium glutamicum variant having improved l-lysine production ability, and method for producing l-lysine using same | |
WO2016032158A1 (en) | Corynebacterium microorganism having l-lysine producing ability and method for producing l-lysine using same | |
WO2010071366A2 (en) | A corynebacteria strain for enhancement of 5'-guanosine monophosphate productivity and a method of producing 5'-guanosine monophosphate using the same | |
WO2017065457A1 (en) | Microorganism having l-threonine producing ability, and method for producing l-threonine using same | |
JPS6070093A (en) | Production of l-tyrosine by fermentation process | |
WO2022231056A1 (en) | Corynebacterium glutamicum variant with improved l-lysine production ability, and method for producing l-lysine using same | |
WO2023063547A1 (en) | Corynebacterium glutamicum variant having improved l-lysine production ability and method for producing l-lysine by using same | |
WO2022231049A1 (en) | Corynebacterium glutamicum variant having improved l-lysine production ability and method for producing l-lysine by using same | |
WO2022231054A1 (en) | Corynebacterium glutamicum variant having improved l-lysine production ability, and method for producing l-lysine using same | |
WO2022191358A1 (en) | Corynebacterium glutamicum variant having improved l-lysine production ability, and method for producing l-lysine by using same | |
WO2023106543A1 (en) | Corynebacterium glutamicum variant having improved l-lysine production ability and method for producing l-lysine by using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180002405.3 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012524667 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13378145 Country of ref document: US |
|
REEP | Request for entry into the european phase |
Ref document number: 2011791415 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011791415 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11791415 Country of ref document: EP Kind code of ref document: A2 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1106092 Country of ref document: BR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: PI1106092 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI1106092 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111129 |